Affinity DataIC50: 50nMAssay Description:Antagonist activity at human beta2 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 100nMAssay Description:Antagonist activity at human beta2 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 200nMAssay Description:Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 251nMAssay Description:Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 398nMAssay Description:Inhibition of human CYP2D6 by LC-MS analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 501nMAssay Description:Antagonist activity at human beta2 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 631nMAssay Description:Antagonist activity at human beta1 receptor expressed in CHO-K1 cells assessed as isoproterenol-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1A(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 2.00E+3nMAssay Description:Antagonist activity at human 5-HT1A receptor expressed in CHO-K1 cells assessed as seretonin-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 2.51E+3nMAssay Description:Inhibition of human CYP2D6 by LC-MS analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 3.16E+3nMAssay Description:Inhibition of human CYP1A2 by LC-MS analysisMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1A(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 3.98E+3nMAssay Description:Antagonist activity at human 5-HT1A receptor expressed in CHO-K1 cells assessed as seretonin-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type CCKA receptor expressed in CHO-K1 cells assessed as CCK8-induced calcium by FDSS assayMore data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M1(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type M1 receptor expressed in CHO-K1 cells assessed as acetylcholine-induced calcium by FDSS assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type A2A receptor expressed in CHO-K1 cells assessed as NECA-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
TargetType-1 angiotensin II receptor(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type AGTR1 receptor expressed in CHO-K1 cells assessed as angiotensin-2-induced calcium by FDSS assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type D2 receptor expressed in CHO-K1 cells assessed as dopamine-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type alpha 2A receptor expressed in CHO-K1 cells assessed as epinephrine-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type opioid-mu receptor expressed in CHO-K1 cells assessed as DAMGO-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type opioid-delta 1 receptor expressed in CHO-K1 cells assessed as DPDPE-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type M3 receptor expressed in CHO-K1 cells assessed as acetylcholine-induced calcium by FDSS assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type A2A receptor expressed in CHO-K1 cells assessed as NECA-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type A3 receptor expressed in CHO-K1 cells assessed as IB MECA-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type AVPR1A receptor expressed in CHO-K1 cells assessed as vassopressin-induced calcium by FDSS assayMore data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type M3 receptor expressed in CHO-K1 cells assessed as acetylcholine-induced calcium by FDSS assayMore data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M2(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type M2 receptor expressed in CHO-K1 cells assessed as acetylcholine-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type D1 receptor expressed in CHO cells assessed as dopamine-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type ETA receptor expressed in CHO-K1 cells assessed as endothelin-1-induced calcium by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type opioid-kappa 1 receptor expressed in CHO-K1 cells assessed as U50488-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1A(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human 5-HT1A receptor expressed in CHO-K1 cells assessed as seretonin-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1B(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human 5-HT1B receptor expressed in CHO-K1 cells assessed as seretonin-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1B(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human 5-HT1B receptor expressed in CHO-K1 cells assessed as seretonin-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 1B(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human 5-HT1B receptor expressed in CHO-K1 cells assessed as seretonin-induced cAMP level by HTRF assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human 5-HT2A receptor expressed in CHO-K1 cells assessed as seretonin-induced calcium level by FDSS assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human 5-HT2A receptor expressed in CHO-K1 cells assessed as seretonin-induced calcium level by FDSS assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2B(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human 5-HT2B receptor expressed in CHO-K1 cells assessed as seretonin-induced calcium level by FDSS assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human 5-HT2C receptor expressed in CHO-K1 cells assessed as seretonin-induced calcium level by FDSS assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 6(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human 5-HT6 receptor expressed in 1321N1 cells assessed as seretonin-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Target5-hydroxytryptamine receptor 7(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type 5-HT7 receptor expressed in HEK cells assessed as seretonin-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type A2A receptor expressed in CHO-K1 cells assessed as NECA-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Inhibition of human CYP2D6 by LC-MS analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type A3 receptor expressed in CHO-K1 cells assessed as IB MECA-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type A3 receptor expressed in CHO-K1 cells assessed as IB MECA-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type alpha 1A receptor expressed in CHO cells assessed as EP-induced calcium by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type alpha 1A receptor expressed in CHO cells assessed as EP-induced calcium by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type alpha 2C receptor expressed in CHO-K1 cells assessed as epinephrine-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type alpha 2C receptor expressed in CHO-K1 cells assessed as epinephrine-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type alpha 2C receptor expressed in CHO-K1 cells assessed as epinephrine-induced cAMP by HTRF assayMore data for this Ligand-Target Pair
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type CCKA receptor expressed in CHO-K1 cells assessed as CCK8-induced calcium by FDSS assayMore data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M3(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type M3 receptor expressed in CHO-K1 cells assessed as acetylcholine-induced calcium by FDSS assayMore data for this Ligand-Target Pair
TargetMuscarinic acetylcholine receptor M2(Homo sapiens (Human))
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Janssen Pharmaceutica N.V.
Curated by ChEMBL
Affinity DataIC50: 5.01E+3nMAssay Description:Antagonist activity at human wild-type M2 receptor expressed in CHO-K1 cells assessed as acetylcholine-induced cAMP by HTRF assayMore data for this Ligand-Target Pair